MedTrace Logo

Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer

NCT07179744 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 635

Last updated 2025-09-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether certain patients can safely omit regional lymph node radiotherapy. These women must have hormone-sensitive, Her2-negative tumors, have 1-3 positive axillary nodes and have RecurIndex low-risk.

Conditions

Sponsors & Collaborators

  • Sun Yat-sen University

    collaborator OTHER

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-06
Primary Completion
2027-07-06
Completion
2032-07-05

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07179744 on ClinicalTrials.gov